Geneos Wealth Management’s FT Vest US Equity Enhance & Moderate Buffer ETF March XMAR Stock Holding History
Bought
Maintained
Sold
Other funds holding XMAR
PP
ACA
FGG
KAS
BBPWM
FIA
RFG
Geneos Wealth Management's XMAR Position: Q1 2026 in Review
Geneos Wealth Management held its FT Vest US Equity Enhance & Moderate Buffer ETF March (XMAR) position steady in Q1 2026 at 475 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1781.
Geneos Wealth Management first reported a position in XMAR in Q4 2024 and has held it in 6 quarters since. The position peaked at $34.9K in Q1 2025. 69 funds tracked by Wall St. Rank hold XMAR as of Q1 2026.
- Geneos Wealth Management held 475 shares of FT Vest US Equity Enhance & Moderate Buffer ETF March worth $19.2K as of Q1 2026.
- Geneos Wealth Management left its FT Vest US Equity Enhance & Moderate Buffer ETF March share count unchanged in Q1 2026.
- FT Vest US Equity Enhance & Moderate Buffer ETF March made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1781 holding.
- Geneos Wealth Management first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF March in Q4 2024 and has held it in 6 quarters since.
- Geneos Wealth Management's FT Vest US Equity Enhance & Moderate Buffer ETF March position peaked at $34.9K in Q1 2025.
- 69 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF March as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.